# ALNYLAM PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v3 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Canonical entity | alpha:company:f95bc419-f349-4b0d-896d-2572577699d0 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 2 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-13T04:45:14.103186+00:00 | | Last reviewed | 2026-09-13T04:45:14.103186+00:00 | ## Identity - Legal name: ALNYLAM PHARMACEUTICALS, INC. - Display name: ALNYLAM PHARMACEUTICALS, INC. ## Leadership - Amy W. Schulman: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - Colleen F. Reitan: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - David E.I. Pyott: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - Dennis A. Ausiello: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - Elliott Sigal: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - Marc D. Hamburg: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - Olivier Brandicourt: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - Peter N. Kellogg: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - Stuart A. Arbuckle: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - Yvonne L. Greenstreet: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2. - Bryan Andrew Supran: Chief Legal Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:3. - Christine Regan Akinc: Chief Corporate Communications Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:3. - Jeffrey V. Poulton: Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:4. - Kevin Joseph Fitzgerald: Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:3. - Piyush Sharma: Chief Ethics & Compliance Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:3. - Pushkal Garg: EVice President of Development & Medical Affairs and Chief Research & Dev. Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:3. - Timothy J. Maines: Chief Technical Operations & Quality Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:3. - Tolga Tanguler: Executive VP & Chief Commercial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:3. - Yvonne L. Greenstreet: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:4. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ALNYLAM PHARMACEUTICALS, INC.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:1. ## Headquarters - US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Entity Status - Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:1. ## Official Website - https://www.alnylam.com. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Published Fact - US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:1. - Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc). - alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:2: [Alnylam Pharmaceuticals DEF 14A 2026-04-06](https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm). - alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:3: [Alnylam Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ALNY). - alpha:evidence:company:f95bc419-f349-4b0d-896d-2572577699d0:4: ALNY executive roster source. ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. - Current index memberships: Unavailable - Index membership events: Unavailable ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc) - [JSON-LD](https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/alnylam-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp